Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet EFLUELDA suspension for injection in pre-filled syringe
- Product code:
- W70905004
- Quantity:
- 1
- Indicated for:
- prevention of influenza
- Route of administration:
- injectable
- Substance:
- inactivated influenza vaccine (vaccine)
- ATC
- J07BB02 — Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
Precautions:
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.
The inactivated influenza vaccine is used to prevent seasonal flu, a viral illness caused by influenza viruses of types A and B. The vaccine contains inactivated influenza viruses that cannot cause the disease but stimulate the immune system to produce specific antibodies against influenza viruses.
The vaccine is administered intramuscularly or subcutaneously, usually annually, and is recommended for all individuals over 6 months of age, especially those in high-risk groups such as the elderly, pregnant women, individuals with chronic illnesses, and healthcare workers.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.
The inactivated influenza vaccine is an important preventive measure for reducing the incidence and severity of seasonal flu, helping to protect public health and alleviate the burden on healthcare systems.
The vaccine is administered intramuscularly or subcutaneously, usually annually, and is recommended for all individuals over 6 months of age, especially those in high-risk groups such as the elderly, pregnant women, individuals with chronic illnesses, and healthcare workers.
Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.
The inactivated influenza vaccine is an important preventive measure for reducing the incidence and severity of seasonal flu, helping to protect public health and alleviate the burden on healthcare systems.
General data about EFLUELDA
- Substance:
- inactivated influenza vaccine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W70905004
- Pharmaceutical form:
- suspension for injection in pre-filled syringe
- Quantity:
- 1
- Product type:
- Original
- Price:
- 212.84 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for inactivated influenza vaccine
Concentrations available for inactivated influenza vaccine
- 15mcg/strain
- 9mcg/strain
- min. 15mcg of each vaccine
- min. 15mcgof each vaccine
- min.15mcgHA ptr. fiecare tip
Compensation lists for EFLUELDA Sanofi
E1 - Sublist E - section E1 with 50% discount from the reference price
- Price
- 212.84 RON
- Copayment
- 106.42 RON
- Patient
- 106.42 RON
E2 - Sublist E - section E2 with 100% discount from the reference price
- Price
- 212.84 RON
- Copayment
- 212.84 RON
- Patient
- 0.00 RON